Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has shared an update.
ResMed Inc has filed a Form 144 for the proposed sale of 3,000 common shares, valued at approximately $845,700, on the NYSE. The shares are being sold by Brett Sandercock, an officer of the company, and were acquired through restricted stock vesting and option grants. This sale reflects a routine transaction and is not expected to significantly impact the company’s operations or market positioning.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$41.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc is a company operating in the healthcare industry, primarily focusing on the development and manufacturing of products for the treatment of sleep disorders, particularly sleep apnea. The company is known for its innovative solutions in respiratory care and has a significant market presence in the medical devices sector.
Average Trading Volume: 835,018
Technical Sentiment Signal: Buy
Current Market Cap: A$63.32B
See more insights into RMD stock on TipRanks’ Stock Analysis page.